CMV retinitis
High ocular CMV copies and mismatched receipts may predict poor visual prognosis in CMV retinitis patients following allogeneic haematopoietic stem cell transplantation
7
Posterior segment manifestations in human immunodeficiency virus/acquired immunodeficiency syndrome patients in rural population of central india
5
Antineurofilament and antiretinal antibodies in AIDS patients with cytomegalovirus retinitis.
5
Ocular Manifestations in HIV Positive and AIDS Patients in Nepal
8
Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients
7
Valganciclovir in the treatment of cytomegalovirus retinitis in HIV-infected patients
9
Human cytomegalovirus (CMV) DNA in plasma reflects quantity of CMV DNA present in leukocytes
5
Prevalence and clinical management of cytomegalovirus retinitis in AIDS patients in shanghai, china
9
Study of 70 cases of posterior uveitis to evaluate the various etiologies and management.
92
Study to determine the frequency of ocular manifestations in HIV/AIDS patients
86
Long-term results of oral valganciclovir for treatment of anterior segment inflammation secondary to cytomegalovirus infection
6
Association of CMV genomic mutations with symptomatic infection and hearing loss in congenital CMV infection
12
Comparison of Quantitative Cytomegalovirus (CMV) PCR in Plasma and CMV Antigenemia Assay: Clinical Utility of the Prototype AMPLICOR CMV MONITOR Test in Transplant Recipients
6
Monitoring of Cytomegalovirus (CMV) Specific Cell Mediated Immunity in Heart Transplant Recipients: Clinical Utility of the QuantiFERON CMV Assay for Management of Posttransplant CMV Infection
8
Detection of cytomegalovirus (CMV) in granulocytes by polymerase chain reaction compared with the CMV antigen test
5
Evaluation of New Quantitative Assays for Diagnosis and Monitoring of Cytomegalovirus Disease in Human Immunodeficiency Virus Positive Patients
9
Comparison of PCR, Antigenemia Assay, and Rapid Blood Culture for Detection and Prevention of Cytomegalovirus Disease after Lung Transplantation
5
Comparison of the Cytomegalovirus (CMV) Enzyme Linked Immunosorbent Spot and CMV QuantiFERON Cell Mediated Immune Assays in CMV Seropositive and Seronegative Pregnant and Nonpregnant Women
5
The status of CMV as a human pathogen.
16
Cytomegalovirus (CMV) Enzyme Linked Immunosorbent Spot Assay but Not CMV QuantiFERON Assay Is a Novel Biomarker To Determine Risk of Congenital CMV Infection in Pregnant Women
6